期刊文献+

高强度聚焦超声治疗肝癌的近期疗效评价 被引量:8

Treatment of hepatocarcinoma with high intensity focused ultrasound
下载PDF
导出
摘要 目的 评价高强度聚焦超声 (HIFU )治疗肝癌的近期效果。方法 对临床病理确诊的 6例肝癌患者 ,选择了 8个病灶接受HIFU治疗 ,根据治疗前后磁共振 (MRI)、血清肿瘤标记物和临床症状的变化等评估近期疗效。结果 MRI表现 :病灶由治疗前的T1WI低信号、T2WI高信号 ,变成治疗后的T1WI高信号、T2WI低信号 (病灶完全覆盖 )或高低不一的混杂信号 (病灶部分覆盖 ) ,呈现完全或部分凝固性坏死的特征性表现 ;动态增强扫描显示病灶由治疗前的信号强化 ,变成治疗后的信号强化减少或消失。患者治疗后血清肿瘤标记物有不同程度的下降、肝区疼痛有不同程度的缓解 ;所有患者治疗后未出现重要脏器功能明显异常和邻近组织脏器损伤等严重并发症。结论 HIFU治疗肝癌局部疗效明确 ,且安全、可行 ,为临床无创性治疗肝癌提供了一种新的手段。 Objective To evaluate the near efficiency of high intensity focused ultrasound (HIFU) in the treatment of hepatocarcinoma.Methods Six patients with 8 masses of hepatic carcinomas were sonicated by HIFU. MRI,serum tumor signs and clinical symptoms were evaluated before and after HIFU sonication for assessing the efficiency of treatment.Results On the MRI,hypointensity of tumor tissues on T1WI and hyperintensity of tumor tissues on T2WI before HIFU and they were changed into hyperintensity on T1WI and hypointensity on T2WI or mixed intensity after HIFU treatment. The enhanced values within tumor tissues on dynamic enhanced MRI post-sonication showed a significant decrease or disappearance comparing to pre-sonication. The serum tumor signs decreased and symptoms alleviated post-sonication. Neither significant abnormality of main organs function including heart,liver and kidney nor local serious complication in which adjacent organs damage was observed post-sonication.Conclusion The use of HIFU in the treatment of hepatic carcinoma is effective,feasible and safe. It is a new noninvasive technique for treatment of hepatic carcinoma.
出处 《中国医学影像技术》 CSCD 2004年第2期279-281,共3页 Chinese Journal of Medical Imaging Technology
关键词 高强度聚焦超声 肝癌 磁共振成像 High intensity focused ultrasound Hepatic carcinoma Magnetic resonance imaging
  • 相关文献

参考文献6

二级参考文献13

共引文献242

同被引文献64

  • 1朱世杰,贾立群,李佩文.艾迪注射液抑制肿瘤新生血管形成的实验研究[J].中国实验方剂学杂志,2008,14(11):55-57. 被引量:27
  • 2陈健,李勤,闵敏,苟新蓉.细胞因子诱导杀伤细胞治疗恶性肿瘤的临床观察[J].西南国防医药,2006,16(2):186-188. 被引量:11
  • 3Liver Cancer Study Group of Japan. Primary liver cancer in Japan. C linicopathologic features and results of surgical treatment [ J ]. Ann Surg,1990,211 (3) :277 -287.
  • 4Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification [ J ]. Semin Liver Dis, 1999, 19 (3) :329 -338.
  • 5Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma:rationale for the design and evaluation of therapeutic trials [ J].Hepatology, 1999,29 (1) :62 -67.
  • 6Fong Y, Sun RL, Jamagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center[ J]. Ann Surg, 1999,229 (6) :790-799.
  • 7Yamadori K, Uda R, Oka M, et al. Anesthetic management for high-intensity focused ultrasound (HIFU) therapy in prostate cancer. Masui, 2007,56(4):446- 449.
  • 8Wu F, Wang ZB, Cao YD, et al. Heat fixation of cancer cells ablated with high-intensity focused ultrasound in patients with breast cancer. AmJ Surg, 2006,192(2):179-184.
  • 9Stewart EA, Rabinoviei J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril, 2006,85 ( 1) : 22-29.
  • 10Fennessy FM, Tempany CM. MRI-guided focused ultrasound surgery of uterine leiomyomas. Acad Radiol, 2005, 12(9):1158- 1166.

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部